Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic

NCT04474301 | Recruiting

• 2 other identifiers: 2020-0470NCI-2020-04587
• Study Type: observational
• Target: 1,152
• Locations: 1 country
• Sites: 1

Brief Summary

The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to health care, finances and social interactions. We will also evaluate the extent to which resiliency factors such as social support, perceived benefits under times of stress, and ability to manage stress may buffer associations between COVID-19 experiences and HRQoL. To meet these objectives, we have developed a 10-minute questionnaire that taps into these areas and is based on prior work addressing concerns of other pandemics or national crises. Participants will have previously consented to protocol PA15-0336 and have provided prior lifestyle data. This will allow us to connect the COVID-19 survey data with prior existing data.

Conditions

COVID-19 Infection; Melanoma

Outcome Measures

Primary Outcomes (8)

• Experiences during the COVID-19 pandemic

  Including exposure, risk factors, testing, isolation, seropositivity, hospitalization, or loss of family or friends.

  Survey completion Up to 2 months

• COVID-19-specific psychological distress

  Survey completion Up to 2 months

• COVID-19-specific health

  Survey completion Up to 2 months

• COVID-19-specific financial and social disruptions

  Survey completion Up to 2 months

• COVID-19-specific perceived benefits and social support

  Survey completion Up to 2 months

• COVID-19-specific health related quality of life (HRQoL)

  Survey completion Up to 2 months

• Effects of COVID-19 experiences on COVID-19-specific psychological distress and HRQoL

  Will evaluate the extent to which resiliency factors such as social support and perceived benefits moderate the effects of COVID-19 experiences on COVID-19-specific psychological distress and HRQoL.

  Survey completion Up to 2 months

• Prior lifestyle data

  Will explore the association between prior lifestyle data collected as part of PA15-0336 and COVID-19-specific psychological distress and HRQoL.

  Survey completion Up to 2 months

Study Arms (1)

Observational (survey administration)

Patients complete a survey over 10 minutes.

Other: Survey Administration

Interventions

Survey Administration OTHER

Complete survey

Observational (survey administration)

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients who have signed consent for PA15-0336.

You may qualify if:

• Patients who have signed consent for PA15-0336
• Has an active email address and can be contacted via MyChart
• Documentation of being alive per the cancer registry

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

• M D Anderson Cancer Center

MeSH Terms

Conditions

COVID-19; Melanoma

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Neuroendocrine Tumors; Neuroectodermal Tumors; Neoplasms, Germ Cell and Embryonal; Neoplasms by Histologic Type; Neoplasms; Neoplasms, Nerve Tissue; Nevi and Melanomas; Skin Neoplasms; Neoplasms by Site; Skin Diseases; Skin and Connective Tissue Diseases

Study Officials

• Lorenzo Cohen

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Lorenzo Cohen

CONTACT

(713) 745-4260; lcohen@mdanderson.org

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 14, 2020
• First Posted: July 16, 2020
• Study Start: June 11, 2020
• Primary Completion (Estimated): December 30, 2026
• Study Completion (Estimated): December 30, 2026
• Last Updated: April 16, 2026

Record last verified: 2026-04

Locations

US (1)